BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17003088)

  • 1. Randomized study to characterize glycemic control and short-term pulmonary function in patients with type 1 diabetes receiving inhaled human insulin (exubera).
    Norwood P; Dumas R; Cefalu W; Yale JF; England R; Riese R; Teeter J
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2211-4. PubMed ID: 17003088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of long-term immunological and pulmonary safety of inhaled human insulin with up to 24 months of continuous therapy.
    Cefalu WT; Bohannon NJ; Edwin Fineberg S; Teeter JG; Schwartz PF; Reis JM; Krasner AS
    Curr Med Res Opin; 2008 Nov; 24(11):3073-83. PubMed ID: 18828959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of inhaled human insulin (exubera) during discontinuation and readministration of therapy in adults with type 2 diabetes: a 3-year randomized controlled trial.
    Rosenstock J; Cefalu WT; Hollander PA; Klioze SS; Reis J; Duggan WT
    Diabetes Technol Ther; 2009 Nov; 11(11):697-705. PubMed ID: 19905885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of inhaled human insulin (Exubera) compared to subcutaneous insulin in children ages 6 to 11 years with type 1 diabetes mellitus: results of a 3-month, randomized, parallel trial.
    White NH; Quattrin T; St Aubin LB; Duggan WT; England RD; Fryburg JS
    J Pediatr Endocrinol Metab; 2008 Jun; 21(6):555-68. PubMed ID: 18717242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of inhaled human insulin (Exubera) during discontinuation and readministration of therapy in adults with type 1 diabetes: A 3-year randomized controlled trial.
    Skyler JS; Hollander PA; Jovanovic L; Klioze S; Krasner A; Riese RJ; Reis J; Schwartz P; Duggan W;
    Diabetes Res Clin Pract; 2008 Nov; 82(2):238-46. PubMed ID: 18824271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year pulmonary safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 2 diabetes.
    Rosenstock J; Cefalu WT; Hollander PA; Belanger A; Eliaschewitz FG; Gross JL; Klioze SS; St Aubin LB; Foyt H; Ogawa M; Duggan WT
    Diabetes Care; 2008 Sep; 31(9):1723-8. PubMed ID: 18535196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trough insulin levels in bronchoalveolar lavage following inhaled human insulin (Exubera) in patients with diabetes mellitus.
    Mendivil CO; Teeter JG; Finch GL; Schwartz PF; Riese RJ; Brain JD
    Diabetes Technol Ther; 2012 Jan; 14(1):50-8. PubMed ID: 21875362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 1 diabetes.
    Skyler JS; Jovanovic L; Klioze S; Reis J; Duggan W;
    Diabetes Care; 2007 Mar; 30(3):579-85. PubMed ID: 17327324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial.
    Rosenstock J; Zinman B; Murphy LJ; Clement SC; Moore P; Bowering CK; Hendler R; Lan SP; Cefalu WT
    Ann Intern Med; 2005 Oct; 143(8):549-58. PubMed ID: 16230721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Inhaled Human Insulin (Exu hera
    White NH; Quattrin T; Aubin LBS; Duggan WT; England RD; Fryburg JS
    J Pediatr Endocrinol Metab; 2020 Oct; 21(6):555-568. PubMed ID: 33600687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Titration of inhaled human insulin (Exubera) in a treat-to-target regimen for patients with type 2 diabetes.
    Hollander PA; Cefalu WT; Mitnick M; Lawrence D; Rosenstock J
    Diabetes Technol Ther; 2010 Mar; 12(3):185-91. PubMed ID: 20151768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year efficacy and safety of AIR inhaled insulin in patients with type 1 diabetes: An open-label randomized controlled trial.
    Garg SK; Mathieu C; Rais N; Gao H; Tobian JA; Gates JR; Ferguson JA; Webb DM; Berclaz PY
    Diabetes Technol Ther; 2009 Sep; 11 Suppl 2():S5-S16. PubMed ID: 19772449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of lung function changes with humoral immunity during inhaled human insulin therapy.
    Teeter JG; Riese RJ
    Am J Respir Crit Care Med; 2006 Jun; 173(11):1194-200. PubMed ID: 16556690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term tolerability of inhaled human insulin (Exubera) in patients with poorly controlled type 2 diabetes.
    Barnett AH; Lange P; Dreyer M; Serdarevic-Pehar M;
    Int J Clin Pract; 2007 Oct; 61(10):1614-25. PubMed ID: 17877648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial.
    Quattrin T; BĂ©langer A; Bohannon NJ; Schwartz SL;
    Diabetes Care; 2004 Nov; 27(11):2622-7. PubMed ID: 15504996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial.
    Fineberg SE; Kawabata T; Finco-Kent D; Liu C; Krasner A
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3287-94. PubMed ID: 15741258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Perspectives of inhaled insulin treatment].
    Chodorowski Z; Sein Anand J
    Przegl Lek; 2007; 64(4-5):365-7. PubMed ID: 17724916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of AIR inhaled insulin compared with subcutaneous insulin in patients having diabetes and asthma: A 12-month, randomized, noninferiority trial.
    Ang E; Lawrence MK; Heilmann CR; Ferguson JA; Tobian JA; Webb DM; Berclaz PY
    Diabetes Technol Ther; 2009 Sep; 11 Suppl 2():S35-44. PubMed ID: 19772447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial.
    Skyler JS; Weinstock RS; Raskin P; Yale JF; Barrett E; Gerich JE; Gerstein HC;
    Diabetes Care; 2005 Jul; 28(7):1630-5. PubMed ID: 15983312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus.
    Ceglia L; Lau J; Pittas AG
    Ann Intern Med; 2006 Nov; 145(9):665-75. PubMed ID: 17088580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.